about
Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a meta-analysisThe use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancerInduction of Apoptosis in MCF-7 Cells via Oxidative Stress Generation, Mitochondria-Dependent and Caspase-Independent Pathway by Ethyl Acetate Extract of Dillenia suffruticosa and Its Chemical ProfileTracing overlapping biological signals in mid-infrared using colonic tissues as a model system.Nanoparticles for Improving Cancer Diagnosis.Serum Levels of Glycoproteins are Elevated in Patients with Ovarian CancerAnalysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study.Biomarkers of HIV-associated Cancer.Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites.Prediction of lung cells oncogenic transformation for induced radon progeny alpha particles using sugarscape cellular automata.MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.Identification and Validation of a Potential Marker of Tissue Quality Using Gene Expression Analysis of Human Colorectal Tissue.Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.Organ Specific Tumor Markers: What's New?Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.ALEX1 may be a novel biomarker for human cervical squamous cell carcinoma.High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy.Clinical potential of gene mutations in lung cancer.A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.Role of DR-70 immunoassay in suspected malignant pleural effusion.Correlation of serum levo-fucose levels as a biomarker with tumor node metastasis staging in oral cancer patients.Serum carcinoembryonic antigen as a tumour marker in patients with endometrial cancerTumor markers: A diagnostic toolIdentification of Transcription Factor YY1 as a Regulator of a Prostate Cancer-Specific Pathway Using Proteomic Analysis.Proteins are potent biomarkers to detect colon cancer progression.Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.Glioma and glioblastoma - how much do we (not) know?Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.Cell Cycle Model System for Advancing Cancer Biomarker Research.Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.Analysis of ARID2 Gene Mutation in Oral Squamous Cell CarcinomaProteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Plasma miRNA can detect colorectal cancer, but how early?Electrochemical affinity biosensors for fast detection of gene-specific methylations with no need for bisulfite and amplification treatments.ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs).Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma
P2860
Q26749419-500EA8A9-EA04-45FE-A2CE-314DA914CC86Q28486906-3CD0752D-9A19-40CC-A52B-641CB1666BFDQ28547953-A56D0D63-39C7-4585-A537-16059B109F27Q30354413-DBCEBDDE-D992-45E7-826C-70049BDBBDB0Q30442412-66DC244B-4BF5-4FBD-998E-FC0EA60F1738Q33774597-56886BC4-44D4-445C-9F0C-967B62DD1818Q33831823-C3AE229F-D277-489A-8D4F-C0C719D8E9B7Q33856851-B6C2D62D-C8B0-452D-BC06-7A3E84F4C7F3Q33946367-5E52D457-5D3C-41A1-AE9F-6B8C28FCD2D2Q34082537-6902CE3B-7F82-4141-9FB2-C7136E66694AQ34326553-33EEAF57-0E75-4560-9264-353463C43DBEQ34536729-8E4CDDD0-66C7-4BF3-8102-80CA00517ADEQ35722632-29E9A291-3547-4292-913D-94B5CF61E7EEQ35790450-9FA705A1-63C5-48F3-91BF-A4B14F51D3B7Q35980584-4A952C0E-4C8A-45B0-9B7A-A7C3FE35E16FQ36050803-7DBF9FC3-8163-4C01-BF50-2CCDDC4AB965Q36095333-2B4D71DB-9420-4549-B1ED-24F0DD032516Q36174234-79E17A5A-ED78-473E-9A07-390E3A05F217Q36316009-7BDC6CFA-690B-4DC3-A1BC-9F0EC0D77B1EQ36541715-91DCEC15-75AA-4087-89C2-E3BC8513C12AQ37345732-079552A8-8973-4650-91DD-18938F15127AQ37356984-C640E900-8041-4907-A979-8B929AA6FB0FQ37367905-134DABD4-49A9-4C47-81DB-EBDF3F805D8FQ37591660-379C1A16-A0D9-4F61-8F0D-F1523C2C6246Q38399742-5155E894-92D1-49DA-BF56-1D301C1C4188Q41456559-74703F5E-959F-4B40-8525-E331A4FE1899Q41714067-7DC20353-3DB7-4BEF-98FF-91F0B0962F40Q42578340-474B3E1C-0392-4B7D-882E-7B83AE28FD83Q47097183-EE968E66-A3E4-4649-946C-45D080D741BFQ47262784-8B89701A-68DE-4E8E-967D-341DF53D2821Q47691581-93D0D725-F629-4CCA-BB94-8666EF3F49BEQ47875981-83AB9F82-F8DB-499D-A5D0-E97CB3565EAEQ54962725-6F5D088C-DF9A-46D5-A228-491A5083497BQ55050221-B6D96FFA-3113-4341-A583-B3698908BD88Q55285442-A77D1C35-DD96-4FB7-BBC4-BF5C9EFCD40AQ55343172-DF74B330-083D-49CB-87C4-FFEB539C15DCQ58775105-2A96FE5E-FA08-46A7-A4AC-AFFB0497C7E3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer biomarkers - current perspectives.
@en
Cancer biomarkers - current perspectives.
@nl
type
label
Cancer biomarkers - current perspectives.
@en
Cancer biomarkers - current perspectives.
@nl
prefLabel
Cancer biomarkers - current perspectives.
@en
Cancer biomarkers - current perspectives.
@nl
P2093
P1476
Cancer biomarkers - current perspectives
@en
P2093
Abdullah Farooque
Amit Verma
Anant Narayan Bhatt
Rohit Mathur
P304
P407
P577
2010-08-01T00:00:00Z